Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

Clinical trial NCT00328120 · COMPLETED

Trial details

NCT number: NCT00328120
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2004-04-01
Primary completion: 2006-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.